Molecular Editing by Nitrogen Insertion
NINSERT aims to develop selective nitrogen insertion methods for late-stage skeletal editing in heterocycles, enhancing drug synthesis and tailoring compound profiles for pharmaceutical research.
Projectdetails
Introduction
NINSERT constitutes a program to embark on selective and mild nitrogen insertions, both within and beyond carbonyl chemistry. Reagent development, catalyst design, and synergistic effects will be evaluated to provide a platform for late-stage skeletal editing, an area that has been recently brought to the forefront of organic chemistry.
Focus on Heterocycles
With a primary emphasis on heterocyclic motifs, commonly encountered in natural products and drug candidates, NINSERT offers a powerful tool to streamline future syntheses of nitrogen-containing compounds. Notably, approximately 59% of all small-molecule drugs feature nitrogen heterocycles, underscoring the profound impact this program will have on pharmaceutical research.
Tailoring Compound Profiles
Adjusting physicochemical properties by late-stage nitrogen insertion will enable medicinal chemists to tailor the overall compound profile on its way to candidate nomination and ultimately clinical studies.
Asymmetric Methods
Furthermore, asymmetric methods, as elucidated in this proposal, will give rise to molecular complexity within the 3D chemical space. Guided by the principles of strain-release and molecular recognition, we will utilize our expertise on asymmetric ring expansion and atom insertion reactions to deliver highly selective methods applicable to both academic and industrial research.
Historical Context
Despite the pioneering work of Beckmann and Schmidt over a century ago, nitrogen insertions have remained significantly constrained over the years, largely due to their substrate limitations, harsh reaction conditions, and unselective outcomes.
Conclusion
The progression to selective and widely applicable nitrogen insertions has been long overdue and marks a major driving force behind the development of NINSERT.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.462.500 |
Totale projectbegroting | € 1.462.500 |
Tijdlijn
Startdatum | 1-3-2025 |
Einddatum | 28-2-2030 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- JOHANNES GUTENBERG-UNIVERSITAT MAINZpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Reconstructing enzymes for novel nitrogen-nitrogen bond forming chemistryReCNNSTRCT aims to develop a versatile enzymatic toolbox for synthesizing N-N bonds, enhancing green chemistry and drug discovery through innovative biocatalytic methods. | ERC Starting... | € 1.500.000 | 2023 | Details |
Harnessing the Catalytic Potential of NitrogenasesGOFIXIT aims to develop a recombinant nitrogenase enzyme system in food crops to enhance biological nitrogen fixation, reducing reliance on harmful industrial fertilizers. | ERC Advanced... | € 2.963.906 | 2024 | Details |
Converting N2 directly into amines through multimetallic catalysisThe project aims to develop innovative multimetallic catalysts for the direct and efficient conversion of dinitrogen (N2) into amines, promoting sustainable amine synthesis. | ERC Starting... | € 1.575.000 | 2024 | Details |
Energy Transfer Catalysis: A Highway to Molecular ComplexityHighEnT aims to innovate synthetic methodologies using visible light-mediated EnT catalysis to create complex organic molecules for pharmacological applications, enhancing chemical space and reaction design. | ERC Advanced... | € 2.499.250 | 2023 | Details |
Thermodynamically Robust Transfer Reagents for Molecular EditingThe project aims to develop safer, robust sulfur-based reagents for transferring functional groups in organic synthesis, enhancing applications in drug discovery and crop science while facilitating commercialization. | ERC Proof of... | € 150.000 | 2025 | Details |
Reconstructing enzymes for novel nitrogen-nitrogen bond forming chemistry
ReCNNSTRCT aims to develop a versatile enzymatic toolbox for synthesizing N-N bonds, enhancing green chemistry and drug discovery through innovative biocatalytic methods.
Harnessing the Catalytic Potential of Nitrogenases
GOFIXIT aims to develop a recombinant nitrogenase enzyme system in food crops to enhance biological nitrogen fixation, reducing reliance on harmful industrial fertilizers.
Converting N2 directly into amines through multimetallic catalysis
The project aims to develop innovative multimetallic catalysts for the direct and efficient conversion of dinitrogen (N2) into amines, promoting sustainable amine synthesis.
Energy Transfer Catalysis: A Highway to Molecular Complexity
HighEnT aims to innovate synthetic methodologies using visible light-mediated EnT catalysis to create complex organic molecules for pharmacological applications, enhancing chemical space and reaction design.
Thermodynamically Robust Transfer Reagents for Molecular Editing
The project aims to develop safer, robust sulfur-based reagents for transferring functional groups in organic synthesis, enhancing applications in drug discovery and crop science while facilitating commercialization.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Inhibitor-Mediated Programming of GlycoformsThe project aims to revolutionize glycan manipulation using Inhibitor-Mediated Programming of Glycoforms (IMProGlyco) to create precision-engineered therapeutic proteins and enhance cellular functions. | EIC Pathfinder | € 2.998.878 | 2025 | Details |
A revolutionary cell programming platform based on the targeted nano-delivery of a transposon gene editing systemThe NANO-ENGINE project aims to develop an affordable, scalable, and safe DNA-based in vivo cell programming technology using Targeted Nanoparticles to enhance accessibility of cell therapies for various diseases. | EIC Pathfinder | € 2.988.377 | 2023 | Details |
Inhibitor-Mediated Programming of Glycoforms
The project aims to revolutionize glycan manipulation using Inhibitor-Mediated Programming of Glycoforms (IMProGlyco) to create precision-engineered therapeutic proteins and enhance cellular functions.
A revolutionary cell programming platform based on the targeted nano-delivery of a transposon gene editing system
The NANO-ENGINE project aims to develop an affordable, scalable, and safe DNA-based in vivo cell programming technology using Targeted Nanoparticles to enhance accessibility of cell therapies for various diseases.